Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
CA 2436421 C · Owner: Goldman, Steven · Inventors: Goldman, Steven; Bahl, Joseph J.; Pennock, Gregory D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Applicants's invention includes a method to treat a patient having congestive heart failure by administering a therapeutically effective amount of 3,5diiodothyropropionic acid. Applicants' invention further includes a method to lower cholesterol blood levels of a patient by administering a therapeutically effective amount of 3,5-diiodothyropropionic acid. Aplicants' invention further includes a synthetic method to prepare 3,5-diiodothyropropionic acid.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 2002 and granted June 14, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.